Photoredox Csp3−Csp2 Reductive Cross‐Couplings of Cereblon Ligands for PROTAC Linker Exploration in Batch and Flow

Abstract

AbstractProteolysis‐targeting chimeras (PROTACs) have recently emerged as powerful molecules for targeted protein degradation. As such, synthetic methods for their modular synthesis are of prime importance in medicinal chemistry. We report the development of both batch and flow photoredox methodologies for Csp3−Csp2 cross‐electrophile couplings of alkyl bromides with E3 ligase‐binding aryl bromides (thalidomide and lenalidomide derivatives). Despite the challenging reaction system, containing several insoluble species, conditions were discovered to facilitate stable processing in an oscillatory flow photochemical reactor. The flow approach can enable processing of larger material quantities in a shorter time period. A range of saturated linker molecules, with various functional handles, were successfully combined with four ligand variants using the developed conditions. Finally, scalability in batch and use of an organic photocatalyst were explored.